首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival
【2h】

Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival

机译:内在约束对成纤维细胞生长和血浆细胞存活的外在限制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

B cells recruited into splenic antibody responses grow exponentially, either in extrafollicular foci as plasmablasts, or in follicles where they form germinal centers. Both responses yield plasma cells. Although many splenic plasma cells survive <3 d, some live much longer. This study shows that early plasma cell death relates to a finite capacity of the spleen to sustain plasma cells rather than a life span endowed by the cell's origin or the quality of antibody it produces. Antibody responses were compared where the peak numbers of plasma cells in spleen sections varied between 100 and 5,000 cells/mm2. In each response, plasmablast clones divided some five times, with the peak numbers of plasma cells produced relating directly to the number of B cells recruited into the response. The spleen seems to have the capacity to sustain between 20 and 100 plasma cells/mm2. When this number is exceeded, there is a loss of excess cells. Immunoglobulin variable region gene sequencing, and 5-bromo-2′-deoxyuridine pulse–chase studies indicate that long-lived splenic plasma cells are a mixture of cells derived from the extrafollicular and germinal center responses and cells derived from virgin and memory B cells. Only a proportion has switched immunoglobulin class.
机译:募集到脾脏抗体反应中的B细胞在成浆细胞的卵泡外灶或形成生发中心的卵泡中呈指数增长。两种反应均产生浆细胞。尽管许多脾浆细胞存活时间<3 d,但仍有一些寿命更长。这项研究表明,早期浆细胞死亡与脾脏维持浆细胞的有限能力有关,而不是与细胞起源或所产生抗体的质量所赋予的寿命有关。比较了脾脏中浆细胞的峰值数量在100和5,000细胞/ mm 2 之间变化的抗体反应。在每个反应中,浆母细胞克隆大约分裂了五次,产生的浆细胞的峰值数量直接与募集到反应中的B细胞数量有关。脾脏似乎能够维持20至100个浆细胞/ mm 2 。超过此数量时,会丢失多余的单元格。免疫球蛋白可变区基因测序和5-bromo-2'-deoxyuridine脉冲追踪研究表明,长寿命的脾浆细胞是源自卵泡外和生发中心反应的细胞与源自原始和记忆B细胞的细胞的混合物。只有一部分转换了免疫球蛋白类别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号